VIDEO: Two Physicians Discuss Paxlovid

Two experts from Vanderbilt University Medical Center, Chief Epidemiologist Dr. Tom Talbot and Chief Medical Officer Dr. Paul Sternberg, sat down together recently to discuss available antiviral treatments for patients who have tested positive for COVID-19, including Paxlovid™. Paxlovid™ is available for many high-risk patients, including older adults (ages 50 years or older, with risk increasing with older age), people who are unvaccinated, and people with certain medical conditions, such as a weakened immune system. Watch this 8-minute video for more information on the treatment.